Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 25034499)

1.

Serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in children.

Peng Z, Mao J, Chen X, Cai F, Gu W, Fu H, Shen H, Wang J, Jin X, Zhu X, Liu A, Shu Q, Du L.

Pediatr Nephrol. 2015 Feb;30(2):301-7. doi: 10.1007/s00467-014-2892-6. Epub 2014 Jul 18.

PMID:
25034499
2.

Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.

Sinha A, Bajpai J, Saini S, Bhatia D, Gupta A, Puraswani M, Dinda AK, Agarwal SK, Sopory S, Pandey RM, Hari P, Bagga A.

Kidney Int. 2014 Mar;85(3):649-58. doi: 10.1038/ki.2013.546. Epub 2014 Jan 15.

PMID:
24429405
3.

[Diagnostic value of soluble urokinase-type plasminogen activator receptor serum levels in adults with idiopathic nephrotic syndrome].

Segarra A, Jatem E, Quiles MT, Arbós MA, Ostos H, Valtierra N, Carnicer C, Agraz I, Salcedo MT.

Nefrologia. 2014;34(1):46-52. doi: 10.3265/Nefrologia.pre2013.Oct.12256. Spanish.

4.

Proteomic profiling identifies haptoglobin as a potential serum biomarker for steroid-resistant nephrotic syndrome.

Wen Q, Huang LT, Luo N, Wang YT, Li XY, Mao HP, Zhang L, Dong XQ, Yu XQ.

Am J Nephrol. 2012;36(2):105-13. doi: 10.1159/000339755. Epub 2012 Jun 30.

PMID:
22759352
6.

Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria.

Vallés P, Peralta M, Carrizo L, Martin L, Principi I, Gonzalez A, Manucha W.

Pediatr Nephrol. 2000 Dec;15(3-4):252-8.

PMID:
11149121
7.

[Interleukin-18 expression in peripheral blood mononuclear cells in children with steroid-resistant nephrotic syndrome].

Jiang HK, Luo G, Jiang H.

Zhongguo Dang Dai Er Ke Za Zhi. 2009 May;11(5):337-40. Chinese.

PMID:
19470251
8.

NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome.

Bennett MR, Piyaphanee N, Czech K, Mitsnefes M, Devarajan P.

Pediatr Nephrol. 2012 May;27(5):807-12. doi: 10.1007/s00467-011-2075-7. Epub 2011 Dec 27.

9.

Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.

Li F, Zheng C, Zhong Y, Zeng C, Xu F, Yin R, Jiang Q, Zhou M, Liu Z.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1903-11. doi: 10.2215/CJN.02370314. Epub 2014 Oct 15.

PMID:
25318750
10.

Clinical significance of serum and urinary soluble urokinase receptor (suPAR) in primary nephrotic syndrome and MPO-ANCA-associated glomerulonephritis in Japanese.

Fujimoto K, Imura J, Atsumi H, Matsui Y, Adachi H, Okuyama H, Yamaya H, Yokoyama H.

Clin Exp Nephrol. 2014 Dec 13. [Epub ahead of print]

PMID:
25500737
11.

[Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis].

Segarra A, Jatem E, Quiles MT, Arbós MA, Ostos H, Valtierra N, Carnicer C, Salcedo MT.

Nefrologia. 2014;34(1):53-61. doi: 10.3265/Nefrologia.pre2013.Oct.12272. Spanish.

12.

Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.

Bock ME, Price HE, Gallon L, Langman CB.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1304-11. doi: 10.2215/CJN.07680712. Epub 2013 Apr 25.

13.

The glomerular permeability factors in idiopathic nephrotic syndrome.

Davin JC.

Pediatr Nephrol. 2015 Apr 30. [Epub ahead of print]

PMID:
25925039
14.

Diagnostic and prognostic significance of suPAR in traumatic brain injury.

Yu L, Wu X, Wang H, Long D, Yang J, Zhang Y.

Neurol India. 2014 Sep-Oct;62(5):498-502. doi: 10.4103/0028-3886.144439.

15.

Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.

Raggam RB, Wagner J, Prüller F, Grisold A, Leitner E, Zollner-Schwetz I, Valentin T, Krause R, Hoenigl M.

J Intern Med. 2014 Dec;276(6):651-8. doi: 10.1111/joim.12238. Epub 2014 Apr 8.

PMID:
24645798
16.

Screening for urinary biomarkers of steroid-resistant nephrotic syndrome in children.

Bai Y, Liu W, Guo Q, Zou Y.

Exp Ther Med. 2013 Mar;5(3):860-864. Epub 2012 Dec 21.

17.

Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome.

Gellermann J, Schaefer F, Querfeld U.

Pediatr Nephrol. 2014 Dec;29(12):2411-4. doi: 10.1007/s00467-014-2913-5. Epub 2014 Aug 17.

PMID:
25129204
18.

Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia.

Mölkänen T, Ruotsalainen E, Thorball CW, Järvinen A.

Eur J Clin Microbiol Infect Dis. 2011 Nov;30(11):1417-24. doi: 10.1007/s10096-011-1236-8. Epub 2011 Apr 12.

PMID:
21479972
19.

Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome.

Hoenigl M, Raggam RB, Wagner J, Valentin T, Leitner E, Seeber K, Zollner-Schwetz I, Krammer W, Prüller F, Grisold AJ, Krause R.

Clin Biochem. 2013 Feb;46(3):225-9. doi: 10.1016/j.clinbiochem.2012.11.004. Epub 2012 Nov 13.

PMID:
23159293
20.

Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis.

Okulu E, Arsan S, Akin IM, Ates C, Alan S, Kilic A, Atasay B.

J Clin Lab Anal. 2014 Jul 10. doi: 10.1002/jcla.21777. [Epub ahead of print]

PMID:
25043869
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk